The evolving landscape of PCSK9 inhibition in cancer
Author:
Funder
NIH
Publisher
Elsevier BV
Subject
Pharmacology
Reference285 articles.
1. Pseurotin A as a novel suppressor of hormone dependent breast cancer progression and recurrence by inhibiting PCSK9 secretion and interaction with LDL receptor;Abdelwahed;Pharmacol. Res.,2020
2. Mutations in PCSK9 cause autosomal dominant hypercholesterolemia;Abifadel;Nat. Genet.,2003
3. Impact of cholesterol metabolism in immune cell function and atherosclerosis;Aguilar-Ballester;Nutrients,2020
4. Targeting PCSK9 in liver cancer cells triggers metabolic exhaustion and cell death by ferroptosis;Alannan;Cells,2023
5. PCSK9 in liver cancers at the crossroads between lipid metabolism and immunity;Alannan;Cells,2022
Cited by 12 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Serum PCSK9 is a novel serological biomarker for the diagnosis and prognosis of pancreatic cancer;PeerJ;2024-09-10
2. Why make it if you can take it: review on extracellular cholesterol uptake and its importance in breast and ovarian cancers;Journal of Experimental & Clinical Cancer Research;2024-09-06
3. The Pleiotropic Effects of Lipid-Modifying Interventions: Exploring Traditional and Emerging Hypolipidemic Therapies;Metabolites;2024-07-17
4. The multifaceted role of PCSK9 in cancer pathogenesis, tumor immunity, and immunotherapy;Medical Oncology;2024-07-15
5. Arenobufagin modulation of PCSK9-mediated cholesterol metabolism induces tumor-associated macrophages polarisation to inhibit hepatocellular carcinoma progression;Phytomedicine;2024-06
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3